India's Sakar Healthcare rises on nod to market cancer injection in EU

Sakar Healthcare

18/06/2025 09:35

** Shares of India's Sakar Healthcare SAKA.NS jump 5% to 345 rupees

** Drugmaker gets approval to market its injection used to treat colorectal cancer in the European Union

** Adds, expects other products, including oral solids and injections, to also receive EU approvals within the next few months

** Trading vols ~115k shares vs 30-day avg of ~25k shares

** YTD stock had risen ~16%

 (Reporting by Hritam Mukherjee in Bengaluru)

 ((Hritam.Mukherjee@thomsonreuters.com;))